Advertisement

Archives of Gynecology and Obstetrics

, Volume 293, Issue 3, pp 659–665 | Cite as

Neuroendocrine tumors in the ovary: histogenesis, pathologic differentiation, and clinical presentation

  • Moiz Vora
  • Robin A. Lacour
  • Destin R. Black
  • Elba A. Turbat-Herrera
  • Xin GuEmail author
Gynecologic Oncology

Abstract

Objective

Primary neuroendocrine tumors in the ovary are rare. These tumors arise from the neuroendocrine cell system of ovarian stroma and surface epithelium, and may also arise from teratoma. We present four primary ovarian neuroendocrine tumors and compare clinicopathologic findings based on tumor histogenesis and site of origin.

Design

Four primary ovarian neuroendocrine tumors were identified from our 10-year departmental archives. H&E slides and immunostains were reviewed and the diagnoses were confirmed. Clinical history, imaging studies, and follow-up data were obtained from medical records.

Results

Patients' ages ranged from 26 to 63. All patients presented with abdominal discomfort and unilateral or bilateral ovarian masses. MRI and CT scans from cases 1 and 2 revealed a solid ovarian mass with no extra-ovarian extension. In case 1, the patient also had a cystic mass in the opposite ovary and an elevated urine 5-HIAA. Microscopically, case 1 revealed a well-differentiated carcinoid tumor with no surface epithelial involvement, and a mature teratoma in the contralateral ovary. Case 2 revealed a stromal carcinoid within the ovarian parenchyma. Imaging studies from cases 3 and 4 showed large complex masses with peritoneal implants and ascites. In both cases 3 and 4, tumor grossly involved both ovarian parenchyma and surface epithelium with multiple pelvic implants. In addition, liver metastases were present in case 4. Microscopically, these tumors were poorly differentiated carcinoma with neuroendocrine differentiation. Histologic sections revealed extensive necrosis, and both cases showed positivity for neuroendocrine markers.

Conclusions

Primary neuroendocrine tumors in the ovary are rare and consist of a group of heterogeneous malignancies that express similar immunohistochemical markers. Primary neuroendocrine tumors that are limited to the ovarian parenchyma often arise from ovarian stroma and teratoma, and are carcinoid tumors with a good prognosis. Neuroendocrine tumors that arise from surface epithelium or dedifferentiate from de novo carcinoma often involve both ovarian stroma and surface epithelium and clinically present as aggressive malignancies with poor prognoses.

Keywords

Ovary Neuroendocrine tumor Carcinoid Carcinoma 

Notes

Compliance with ethical standards

Conflict of interest

None.

References

  1. 1.
    Gardner GJ, Reidy-Lagunes D, Gehrig PA (2011) Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol 122(1):190–198. doi: 10.1016/j.ygyno.2011.04.011 CrossRefPubMedGoogle Scholar
  2. 2.
    Rouzbahman M, Clarke B (2013) Neuroendocrine tumors of the gynecologic tract: select topics. Semin Diagn Pathol 30(3):224–233. doi: 10.1053/j.semdp.2013.06.007 CrossRefPubMedGoogle Scholar
  3. 3.
    Robboy SJ, Norris HJ, Scully RE (1975) Insular carcinoid primary in the ovary. A clinicopathologic analysis of 48 cases. Cancer 36(2):404–418CrossRefPubMedGoogle Scholar
  4. 4.
    Dundr P, Fischerova D, Povysil C, Cibula D (2008) Primary pure large-cell neuroendocrine carcinoma of the ovary. Pathol Res Pract 204(2):133–137. doi: 10.1016/j.prp.2007.09.004 CrossRefPubMedGoogle Scholar
  5. 5.
    Veras E, Deavers MT, Silva EG, Malpica A (2007) Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases. Am J Surg Pathol 31(5):774–782. doi: 10.1097/01.pas.0000213422.53750.d1 CrossRefPubMedGoogle Scholar
  6. 6.
    Roth LM, Goheen MP, Broshears JR (2012) Malignant Brenner tumor of the ovary with transformation to trabecular carcinoid: an immunocytochemical and electron microscopic study. Int J Gynecol Pathol 31(1):91–97. doi: 10.1097/PGP.0b013e3182230e10 CrossRefPubMedGoogle Scholar
  7. 7.
    Mhawech-Fauceglia P, Odunsi K, Dim D, Nowak N, Lele S, Cheney RT, Pejovic T (2008) Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: mystery resolved? Int J Gynecol Pathol 27(4):539–546. doi: 10.1097/PGP.0b013e31816bcda4 CrossRefPubMedGoogle Scholar
  8. 8.
    Eichhorn JH, Lawrence WD, Young RH, Scully RE (1996) Ovarian neuroendocrine carcinomas of non-small-cell type associated with surface epithelial adenocarcinomas. A study of five cases and review of the literature. Int J Gynecol Pathol 15(4):303–314CrossRefPubMedGoogle Scholar
  9. 9.
    Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4):934–959. doi: 10.1002/cncr.11105 CrossRefPubMedGoogle Scholar
  10. 10.
    Meinhold-Heerlein I, Hauptmann S (2014) The heterogeneity of ovarian cancer. Arch Gynecol Obstet 289(2):237–239. doi: 10.1007/s00404-013-3114-3 CrossRefPubMedGoogle Scholar
  11. 11.
    Talerman A (1984) Carcinoid tumors of the ovary. J Cancer Res Clin Oncol 107(2):125–135CrossRefPubMedGoogle Scholar
  12. 12.
    Diaz-Montes TP, Rosenthal LE, Bristow RE, Grumbine FC (2006) Primary insular carcinoid of the ovary. Gynecol Oncol 101(1):175–178. doi: 10.1016/j.ygyno.2005.10.015 CrossRefPubMedGoogle Scholar
  13. 13.
    Davis KP, Hartmann LK, Keeney GL, Shapiro H (1996) Primary ovarian carcinoid tumors. Gynecol Oncol 61(2):259–265. doi: 10.1006/gyno.1996.0136 CrossRefPubMedGoogle Scholar
  14. 14.
    Kurabayashi T, Minamikawa T, Nishijima S, Tsuneki I, Tamura M, Yanase T, Hashidate H, Shibuya H, Motoyama T (2010) Primary strumal carcinoid tumor of the ovary with multiple bone and breast metastases. J Obstet Gynaecol Res 36(3):567–571. doi: 10.1111/j.1447-0756.2010.01231.x CrossRefPubMedGoogle Scholar
  15. 15.
    Collins RJ, Cheung A, Ngan HY, Wong LC, Chan SY, Ma HK (1991) Primary mixed neuroendocrine and mucinous carcinoma of the ovary. Arch Gynecol Obstet 248(3):139–143CrossRefPubMedGoogle Scholar
  16. 16.
    Alenghat E, Okagaki T, Talerman A (1986) Primary mucinous carcinoid tumor of the ovary. Cancer 58(3):777–783CrossRefPubMedGoogle Scholar
  17. 17.
    Buis CC, van Doorn HC, Dinjens WN, Ewing PC (2010) Mucinous carcinoid of the ovary: report of a case with metastasis in the contralateral ovary after 10 years. Rare Tumors 2(3):e39. doi: 10.4081/rt.2010.e39 PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Baker PM, Oliva E, Young RH, Talerman A, Scully RE (2001) Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases. Am J Surg Pathol 25(5):557–568CrossRefPubMedGoogle Scholar
  19. 19.
    Strosberg J, Nasir A, Cragun J, Gardner N, Kvols L (2007) Metastatic carcinoid tumor to the ovary: a clinicopathologic analysis of seventeen cases. Gynecol Oncol 106(1):65–68. doi: 10.1016/j.ygyno.2007.02.034 CrossRefPubMedGoogle Scholar
  20. 20.
    Rabban JT, Lerwill MF, McCluggage WG, Grenert JP, Zaloudek CJ (2009) Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary. Int J Gynecol Pathol 28(1):41–48. doi: 10.1097/PGP.0b013e31817a8f51 CrossRefPubMedGoogle Scholar
  21. 21.
    Lin X, Saad RS, Luckasevic TM, Silverman JF, Liu Y (2007) Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin. Appl Immunohistochem Mol Morphol 15(4):407–414. doi: 10.1097/01.pai.0000210416.53493.0f CrossRefPubMedGoogle Scholar
  22. 22.
    Desouki MM, Lioyd J, Xu H, Cao D, Barner R, Zhao C (2013) CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Hum Pathol 44(11):2536–2541. doi: 10.1016/j.humpath.2013.06.014 CrossRefPubMedGoogle Scholar
  23. 23.
    McCluggage WG, McKenna M, McBride HA (2007) CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors. Int J Gynecol Pathol 26(3):322–327. doi: 10.1097/01.pgp.0000236947.59463.87 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Moiz Vora
    • 1
  • Robin A. Lacour
    • 2
  • Destin R. Black
    • 2
  • Elba A. Turbat-Herrera
    • 1
    • 2
  • Xin Gu
    • 1
    Email author
  1. 1.Department of PathologyLouisiana State University Health Sciences CenterShreveportUSA
  2. 2.Department of Obstetrics and GynecologyLouisiana State University Health Sciences CenterShreveportUSA

Personalised recommendations